160 related articles for article (PubMed ID: 14670649)
1. Overview on the effects of progestins on bone.
Thijssen JH
Maturitas; 2003 Dec; 46 Suppl 1():S77-87. PubMed ID: 14670649
[TBL] [Abstract][Full Text] [Related]
2. Long-term effects of progestins on bone quality and fractures.
Thijssen JH
Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():45-52. PubMed ID: 17943539
[TBL] [Abstract][Full Text] [Related]
3. Prevention and treatment of osteoporosis with hormone replacement therapy.
Christiansen C
Int J Fertil Menopausal Stud; 1993; 38 Suppl 1():45-54. PubMed ID: 8499959
[TBL] [Abstract][Full Text] [Related]
4. Effect of progestins with different glucocorticoid activity on bone metabolism.
Ishida Y; Mine T; Taguchi T
Clin Endocrinol (Oxf); 2008 Mar; 68(3):423-8. PubMed ID: 17973947
[TBL] [Abstract][Full Text] [Related]
5. [Postmenopausal hormonal treatment: conventional hormone replacement therapy or tibolone? Effects on bone].
Reginster JY
J Gynecol Obstet Biol Reprod (Paris); 2002 Oct; 31(6):541-9. PubMed ID: 12407324
[TBL] [Abstract][Full Text] [Related]
6. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 3. Effects of ovarian hormone therapy on skeletal and extraskeletal tissues in women.
Josse RG
CMAJ; 1996 Oct; 155(7):929-34. PubMed ID: 8837542
[TBL] [Abstract][Full Text] [Related]
7. [Estrogens, progestins and the bone].
Ribot C
Rev Prat; 1993 Dec; 43(20):2619-23. PubMed ID: 8146561
[TBL] [Abstract][Full Text] [Related]
8. [Basic principles of hormone replacement therapy in the postmenopause].
Dören M
Ther Umsch; 2000 Oct; 57(10):628-34. PubMed ID: 11081374
[TBL] [Abstract][Full Text] [Related]
9. [Bones are breaking without estrogen].
Komulainen M; Tuppurainen M; Kröger H
Duodecim; 2003; 119(22):2183-9. PubMed ID: 14702807
[No Abstract] [Full Text] [Related]
10. Effects of oestrogens and progestogens on coronary atherosclerosis and osteoporosis of monkeys.
Adams MR; Williams JK; Clarkson TB; Jayo MJ
Baillieres Clin Obstet Gynaecol; 1991 Dec; 5(4):915-34. PubMed ID: 1822826
[TBL] [Abstract][Full Text] [Related]
11. Prevention of postmenopausal osteoporosis with oestrogen replacement therapy and associated compounds: update on clinical trials since 1995.
Dören M; Samsioe G
Hum Reprod Update; 2000; 6(5):419-26. PubMed ID: 11045872
[TBL] [Abstract][Full Text] [Related]
12. An economic analysis of hormone replacement therapy for the prevention of fracture in young postmenopausal women.
Lamy O; Krieg MA; Burckhardt P; Wasserfallen JB
Expert Opin Pharmacother; 2003 Sep; 4(9):1479-88. PubMed ID: 12943477
[TBL] [Abstract][Full Text] [Related]
13. The menopause and the skeleton: key issues.
Kanis JA
Baillieres Clin Obstet Gynaecol; 1996 Sep; 10(3):469-81. PubMed ID: 8931906
[TBL] [Abstract][Full Text] [Related]
14. [Indications for hormone replacement therapy].
Birkhäuser MH
Ther Umsch; 2000 Oct; 57(10):635-42. PubMed ID: 11081375
[TBL] [Abstract][Full Text] [Related]
15. Increased reduction in bone density and skin thickness in postmenopausal women on long-term corticosteroid therapy. A suggested role for estrogen add back therapy.
Baron YM; Brincat M; Galea R
Adv Exp Med Biol; 1999; 455():429-36. PubMed ID: 10599380
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of progestins on the circulating IGF-I system.
Campagnoli C; Abbà C; Ambroggio S; Peris C
Maturitas; 2003 Dec; 46 Suppl 1():S39-44. PubMed ID: 14670644
[TBL] [Abstract][Full Text] [Related]
17. Effect of teriparatide [rhPTH(1-34)] on BMD when given to postmenopausal women receiving hormone replacement therapy.
Ste-Marie LG; Schwartz SL; Hossain A; Desaiah D; Gaich GA
J Bone Miner Res; 2006 Feb; 21(2):283-91. PubMed ID: 16418784
[TBL] [Abstract][Full Text] [Related]
18. Hormones and bone health in postmenopausal women.
Lindsay R
Endocrine; 2004 Aug; 24(3):223-30. PubMed ID: 15542889
[TBL] [Abstract][Full Text] [Related]
19. Metabolic effects of estrogens and progestins.
LaRosa JC
Fertil Steril; 1994 Dec; 62(6 Suppl 2):140S-146S. PubMed ID: 7958008
[TBL] [Abstract][Full Text] [Related]
20. The relationship of biochemical markers of bone turnover to bone density changes in postmenopausal women: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial.
Marcus R; Holloway L; Wells B; Greendale G; James MK; Wasilauskas C; Kelaghan J
J Bone Miner Res; 1999 Sep; 14(9):1583-95. PubMed ID: 10469288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
